Soleus Capital Management’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-13,000
Closed -$230K 80
2021
Q4
$230K Sell
13,000
-28,000
-68% -$495K 0.02% 64
2021
Q3
$862K Buy
+41,000
New +$862K 0.13% 66